Skip to content
  • Wednesday, 1 July 2026
  • 2:04 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Kyowa Kirin Secures FDA Approval for Enhanced Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia
Pharmaceutical R&D

Kyowa Kirin Secures FDA Approval for Enhanced Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia

Teuku Ryan May 16, 2026 0

Kyowa Kirin has announced a significant advancement in the treatment landscape for X-linked hypophosphatemia (XLH) in adult patients, following the…

Read More
Gas streaming off comet 41P probably slowed it to a stop and began rotating it the other wayThe Unforeseen Discrepancy: A Deep Dive into Outlier Detection Methods on Real-World DataRecord-breaking photodetector captures light in just 125 picosecondsTWiV 1284: Clinical Update with Dr. Daniel Griffin
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
World-first gene editing application unveils master regulator of human embryo developmentNavigating the Knowledge Gap: How Workforce Shifts and Advanced Therapies Threaten Biopharma’s Critical Tech Transfer ProcessAnixa Biosciences Secures Key Patent for Breast Cancer Vaccine Technology in South Korea, Expanding Global Intellectual Property PortfolioAn abundance of food may trigger this microbe’s strange transformation
YOU MAY HAVE MISSED
Biotech & Genetic Research
World-first gene editing application unveils master regulator of human embryo development
Jia Lissa Jul 1, 2026
Laboratory Automation & Robotics
Navigating the Knowledge Gap: How Workforce Shifts and Advanced Therapies Threaten Biopharma’s Critical Tech Transfer Process
Lana Keisha Jul 1, 2026
Pharmaceutical R&D
Anixa Biosciences Secures Key Patent for Breast Cancer Vaccine Technology in South Korea, Expanding Global Intellectual Property Portfolio
Teuku Ryan Jul 1, 2026
Environmental & Analytical Chemistry
An abundance of food may trigger this microbe’s strange transformation
Abdurrohim Arsyad Jul 1, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ